Literature DB >> 11383916

Bone mineral density in acromegaly: does growth hormone excess protect against osteoporosis?

I Chiodini1, V Trischitta, V Carnevale, A Liuzzi, A Scillitani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11383916     DOI： 10.1007/BF03343859

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  25 in total

1.  Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.

Authors:  M J Kayath; J G Vieira
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  The nature of the metabolic bone disorder in acromegaly.

Authors:  B L Riggs; R V Randall; H W Wahner; J Jowsey; P J Kelly; M Singh
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

Review 3.  Growth hormone, body composition, and aging.

Authors:  D Rudman
Journal:  J Am Geriatr Soc       Date:  1985-11       Impact factor: 5.562

4.  Total and non-dialyzable urinary hydroxyproline in acromegalics and control subjects.

Authors:  J Halse; J O Gordeladze
Journal:  Acta Endocrinol (Copenh)       Date:  1981-04

5.  Iliac crest bone mass and remodelling in acromegaly.

Authors:  J Halse; F Melsen; L Mosekilde
Journal:  Acta Endocrinol (Copenh)       Date:  1981-05

Review 6.  Growth hormone (replacement) therapy in adults: bone and calcium metabolism.

Authors:  E A van der Veen; J C Netelenbos
Journal:  Horm Res       Date:  1990

Review 7.  Human growth hormone and human aging.

Authors:  E Corpas; S M Harman; M R Blackman
Journal:  Endocr Rev       Date:  1993-02       Impact factor: 19.871

8.  Effects of human growth hormone in men over 60 years old.

Authors:  D Rudman; A G Feller; H S Nagraj; G A Gergans; P Y Lalitha; A F Goldberg; R A Schlenker; L Cohn; I W Rudman; D E Mattson
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

9.  Bone mineral density and circulating cytokines in patients with acromegaly.

Authors:  S Longobardi; C Di Somma; F Di Rella; N Angelillo; D Ferone; A Colao; B Merola; G Lombardi
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

10.  Biochemical assessment of bone formation and resorption in acromegaly.

Authors:  S Ezzat; S Melmed; D Endres; D R Eyre; F R Singer
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958
View more
  5 in total

1.  Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.

Authors:  Marek Bolanowski; Jacek Daroszewski; Marek Medraś; Beata Zadrozna-Sliwka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 2.  Musculoskeletal Effects of Altered GH Action.

Authors:  Jonathan A Young; Shouan Zhu; Edward O List; Silvana Duran-Ortiz; Yosri Slama; Darlene E Berryman
Journal:  Front Physiol       Date:  2022-05-19       Impact factor: 4.755

3.  Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

Authors:  S V Lim; M Marenzana; M Hopkinson; E O List; J J Kopchick; M Pereira; B Javaheri; J P Roux; P Chavassieux; M Korbonits; C Chenu
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

Review 4.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 5.  Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.

Authors:  Vittorio Locatelli; Vittorio E Bianchi
Journal:  Int J Endocrinol       Date:  2014-07-23       Impact factor: 3.257
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.